comparemela.com
Latest Breaking News On - Nasdaq imrn - Page 1 : comparemela.com
Immuron CEO, Steven Lydeamore Investor Webinar
MELBOURNE, Australia, Nov. 28, 2023 (GLOBE NEWSWIRE) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated.
Melbourne
Victoria
Australia
Australian
Steven-lydeamore
Nasdaq
Immuron-limited
Board-of-immuron
Microcaps-morning
Nasdaq-imrn
Immuron-limited
Immuron
Immuron CEO Steven Lydeamore Investor Webinar Presentation
MELBOURNE, Australia, Nov. 13, 2023 (GLOBE NEWSWIRE) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated.
Australia
Melbourne
Victoria
Australian
Steven-lydeamore
Nasdaq
Immuron-limited
Board-of-immuron
Nasdaq-imrn
Immuron-limited
Immuron
Immuron US DoD Naval Medical Research Center responds to
MELBOURNE, Australia, Jan. 25, 2023 (GLOBE NEWSWIRE) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated.
Australia
Melbourne
Victoria
Australian
Steven-lydeamore
Naval-medical-research-center
Johns-hopkins-university
Bloomberg-school-of-public-health
Drug-administration
Nasdaq
Immuron-limited
Investigational-new-drug
Immuron appoints Mr. Steven Lydeamore as Chief Executive
MELBOURNE, Australia, May 05, 2022 (GLOBE NEWSWIRE) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on.
Australia
United-states
Melbourne
Victoria
Canada
Australian
Canadian
Paul-brennan
Steven-lydeamore
Jerry-kanellos
Roger-aston
Us-department-of-defense
vimarsana © 2020. All Rights Reserved.